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Abstract Development of clinical MEG will provide biomarkers of neurode-
generative disorders by producing functional and effective connectivity measures
within and between distinct functional brain areas. It is highly probable that
neurodegenerative disorders damage these connections early in their course and
detection of such changes will be feasible with sophisticated signal analysis of
MEG data. Combining MEG and nTMS has already proven to be valuable in
clinical evaluations. Such combinations will assist us in understanding the com-
plex brain networks and the effective connectivity within them both in the healthy
and diseased brains.
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1 MEG in Clinical Connectivity Studies
The trend in the MEG community, as well as in the neuroscience community in
general, is to reveal the brain functions creating the unified perceptions of the world,
despite the parcellated presentation of its features in our brains. Higher level cog-
nitive functions such as attention, working memory and sensory awareness also
arise from activations in widespread cortical networks. The complete view/model of
these functional networks will require understanding of anatomical, functional and
effective connectivity within and between distinct functional brain areas. MEG,
with its excellent temporal and tolerable spatial accuracy will definitively play an
important role in this endeavor (e.g., Palva et al. 2010; Hipp et al. 2012).
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The advances of neuroscience and clinical applications of MEG have been linked
closely to progress of instrumentation and signal analysis methods. Development of
instrumentation provides new possibilities as ‘‘hypothesis generating’’ research,
complementing the traditional ‘‘hypothesis testing’’ approaches.
Studies of signal conduction between different brain areas using MEG were first
started in patients with epilepsy. Already the early efforts demonstrated that MEG is
able to identify source locations of epileptiform activity and map its spread to the
opposite hemisphere (Barth et al. 1982). More recent studies have convincingly
shown the usefulness of MEG studies in planning epilepsy surgery. MEG improves
the treatment plan in about 20–30 % of the patients (Sutherling et al. 2008;
Knowlton et al. 2009; de Tiege et al. 2012). However, source localization of the
earliest epileptiform activity, not a detailed analysis of its spread, has been the main
target of MEG studies in epilepsy (for a review, see, e.g., Mäkelä et al. 2006). The
significance of tracking the spread of epileptiform activity may increase along with
developments of epilepsy surgery planning, e.g., in increased use of stereotactic
EEG as opposed to subdural grid recordings.
Recent developments have made studies of such ‘‘clinical connectivity’’ more
precise. New, more comfortable gantries and continuous head position localization
have made ictal MEG recordings more convenient, and they localize ictal onset zone
with high sensitivity and specificity at the brain lobe level. Sources of ictal onset
MEG signals and interictal dipole clusters are essentially equally specific in esti-
mation of the ictal onset zone as defined by ECoG, but ictal MEG is more sensitive
(Medvedovsky et al. 2012). A combination of MEG with precisely time-locked
video recordings has enhanced the identification of ictal events and eased the rec-
ognition of artifacts (Zhdanov et al. 2013). These applications, developed in clinical
studies, will also definitively assist sophisticated basic research experiments, e.g., by
guiding the data analysis into precisely selected time windows of required behav-
iors and provide additional information for MEG ‘‘metadata’’ storage.
MEG may also provide tools to improve diagnostics of neurodegenerative
disorders. In these conditions, detection of functional disconnection between brain
regions will be crucial. For example, early AD pathology results in abnormal
interactions between neuronal systems even before the onset of clinical signs and
symptoms (Delbeuck et al. 2003; Brier et al. 2012). MEG is a useful tool to
identify a ‘‘signature’’ of altered functional connectivity that can distinguish
pathological processes from normal cognition (Stam et al. 2009). MEG studies
may provide unique information regarding the changes in brain function respon-
sible for the development of clinical dementia. This should help to direct the
development of treatment strategies (e.g., as an endpoint in clinical trials), and in
the tracking of disease progression. Because MEG is sensitive to dendritic activity
at the synaptic level (Murakami and Okada 2006), it may be able to detect
pathology even before there is evidence of other ‘‘positive’’ neuroimaging bio-
markers (e.g., in vivo amyloid imaging; for a review, see Zamrini et al. 2011).
The present connectivity analysis methods require relatively long recordings of
high-quality signals for providing meaningful results. Exquisite experimental
setups are needed to avoid problems related to varying vigilance. Moreover,
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sophisticated movement correction and artifact suppression are required for
complete realization of their clinical value. Fortunately, MEG noise suppression
methods have developed rapidly. The signal space separation algorithm (SSS)
allows the recognition of magnetic signals from different subspaces, e.g., from the
head and its surroundings (Taulu and Simola 2006). The removal of the signals
that appear statistically similar in both subspaces strongly suppresses the artifacts
generated even in the close vicinity of the sensors, e.g., by electric stimulation of
subthalamic electrodes in patients with Parkinson’s disease. This expands the
MEG applications into studies of effects of deep brain stimulation on spontaneous
brain activity in different neurodegenerative diseases (Airaksinen et al. 2012). The
present efficacy of the SSS method can probably be enhanced further by opti-
mizing the MEG sensor array to also include elements measuring the tangential
components of the extracranial magnetic field (Nurminen et al. 2013). Besides
external noise, random sensor noise may also deteriorate data quality. It is possible
to use SSS for simultaneous modeling of the correlated signals from the brain and
magnetic interference, and the uncorrelated part (from sensor noise) of a multi-
channel MEG signal, and thus aid in removing the uncorrelated part from the
source estimation. This approach decreases the white noise level with a factor of
about 2–4 while the physiological spectral peaks remain intact (Taulu et al. 2012).
This is particularly important in single-trial analysis of evoked responses, and in
analyzing high-frequency signals having relatively poor signal-to noise ratio. The
method may also have clinical relevance e.g., in detecting high-frequency epi-
leptiform signals (Helle et al. 2012). These developments will definitely assist in
obtaining more crisp data for connectivity analyses, and also aid in applying the
new analysis methods in the clinical diagnostics.
Time will tell, whether new MEG analysis methods searching for cortico-
cortical spatial (Schnitzler and Gross 2005), phase-related (Palva et al. 2010), and
temporal correlations (Montez et al. 2009) of spontaneous MEG networks in signal
or source spaces will produce robust biomarkers of disease in individual patients.
The complex methods used in data mining and complicated statistics associated
with them may be relatively impenetrable for clinical users. In order to further the
integration of clinical MEG results into routine patient flow, the analyses also need
to be fast and understandable to the clinical teams utilizing them. The hypotheses
and presumptions underlying the modeling need to be clear, and the effects of
various details of the models required for the completion of the final results need to
be thoroughly understood. Clinical decision making is seldom based on one
methodology only. Nevertheless, developers of new analysis methods for such
purposes may benefit by placing themselves into the clinical situation, i.e., as a
target for the planned procedures, or to consider their willingness to use preventive
medication for the next 20 years, based on data analysis results conducted by a
technician. Although solving such usability problems is not necessarily attractive
for researchers in basic neuroscience, it is highly important in clinical research and
particularly in MEG clinical applications.
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2 Combination of MEG with Navigated Transcranial
Magnetic Stimulation
The physics underlying noninvasive transcranial magnetic stimulation (TMS) can
be considered as the reverse of MEG; instead of picking up tiny magnetic signals
from the cortex, it utilizes fast, strong (about 2 T) magnetic pulses to modify
cortical activity. Navigated TMS (nTMS) displays a dynamic estimate of the
stimulus-induced electric field on the patient’s individual 3-D brain MRI recon-
struction, and enables selection of localized stimulation targets from it. The effects
of nTMS can be tested on the source areas selected from MEG. For example,
nTMS delivered to secondary somatosensory cortex area, pinpointed by MEG,
speeds up somatomotor reactivity (Raij et al. 2008), and rhythmic TMS to the
MEG-identified source areas of spontaneous oscillatory activity entrains these
oscillations at the stimulation frequency (Thut et al. 2011) (Fig. 1).
In the foreseeable future, TMS devices will develop towards more complex
delivery of pulses into multiple sites, monitoring the effects of TMS by electro-
physiological measures, and even guiding the TMS properties by the induced
Fig. 1 Comparison of mapping with MEG, nTMS and ECoG in a patient with epilepsy, depicted
on a 3-D reconstruction of the patient’s brain. Epileptiform region near the motor cortex, as
depicted by MEG, is colored yellow. Red dots indicate sites producing motor evoked potentials in
nTMS. Green dot indicates the anatomic indicator of the hand motor area. Red circles mark
electrodes where stimulation elicited typical seizures, dark blue circle indicates site producing
hand movements and a seizure, and light blue circles indicate sites producing hand and arm
movements. The surgeon removed the cortical area delineated by black lines. After the operation,
the patient has remained free of seizures. Modified from Vitikainen et al. (2009)
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modifications. Although simultaneous TMS and MEG recordings probably will
not be feasible, MEG will be a crucial tool in interpreting the electrophysiological
connectivity utilized in such studies. Combining MEG and nTMS has already
proven to be valuable in clinical evaluations (e.g. Vitikainen et al. 2009; Mäkelä
et al. 2013, see also Fig. 1). Such combinations will assist us in understanding the
complex brain networks, the effective connectivity within them both in the healthy
and diseased brains.
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